Finoriq research workspace
Beta Bionics, Inc. (BBNX) Historical Metrics
Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development. Review BBNX valuation ratios, fundamentals, and filing metrics on Finoriq.
Company Snapshot
Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older. The company is also developing Patch Pump, an insulin pump that is designed to adhere directly to the skin and administer insulin without the need for tubing; Bihormonal iLet, which combines automated delivery of insulin and glucagon; and iLet to treat people with insulin-dependent type-2 diabetes. It has collaboration and license agreement with Xeris Pharmaceuticals, Inc. (Xeris) to develop and commercialize a pump-compatible glucagon formulation; and development and commercialization agreement with Abbott Diabetes Care Inc. to develop and commercialize an automated insulin delivery system. The company was incorporated in 2015 and is headquartered in Irvine, California.
- Company
- Beta Bionics, Inc. (BBNX)
- Ticker
- BBNX
- Market Cap
- $799.7M
- Latest Price
- $17.95
- Industry
- Medical Devices
Beta Bionics, Inc. (BBNX) Current Valuation Metrics
Static valuation preview for Beta Bionics, Inc. (BBNX). Market data retrieved 2026-07-09. Filing currency USD.
| Metric | Value | Source |
|---|---|---|
| P/SMarket cap divided by latest TTM revenue. | 6.65x | Revenue | TTM Q1 2026 |
| Earnings YieldLatest TTM net income divided by market cap. | -9.1% | Net Income | TTM Q1 2026 |
| Operating Cash Flow YieldLatest TTM operating cash flow divided by market cap. | -7.5% | Operating Cash Flow | TTM Q1 2026 |
| Price / BookMarket cap divided by stockholders' equity. | 2.7x | Stockholders' Equity | Q1 2026 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.